Core Viewpoint - AS Merko Ehitus has outlined its financial reporting schedule for 2026, including key dates for interim and annual reports, as well as the annual general meeting for shareholders [1] Financial Reporting Schedule - The unaudited interim report for the 12 months and 4th quarter of 2025 will be published on February 5, 2026 [1] - The audited annual report for 2025 is scheduled for April 6, 2026 [1] - The unaudited interim report for the first three months of 2026 will be released on May 7, 2026 [1] - The unaudited interim report for the first half of 2026 will be available on August 6, 2026 [1] - The unaudited interim report for the first nine months of 2026 will be published on November 5, 2026 [1] Shareholder Meeting - The annual general meeting for the approval of the 2025 annual report will occur in the second quarter of 2026, with the exact time and location to be announced later [1] Company Overview - AS Merko Ehitus operates in the construction and real estate development sectors across Estonia, Latvia, and Lithuania [2] - As of the end of 2024, the company employed 605 people and reported a revenue of EUR 539 million for that year [2]

Core Points - EfTEN Real Estate Fund AS has scheduled the publication of its financial results and the annual general meeting of shareholders for 2026 [1] Financial Results Schedule - The company plans to release unaudited results for Q4 2025 and the full year 2025 on January 29, 2026 [1] - Audited results for the year 2025 will be published on February 27, 2026 [1] - The annual general meeting is set for April 7, 2026 [1] - Interim results for Q1 will be available on April 30, 2026 [1] - Q2 interim results are scheduled for July 30, 2026 [1] - Q3 interim results will be published on October 29, 2026 [1]

Core Insights - Faraday Future has successfully entered the Florida market by signing a deposit agreement with Golden Hills Investment LLC for 2,000 FX Super One MPVs, marking a significant sales breakthrough [2][15] - The company has now penetrated six out of eight key target states in its first-phase rollout, demonstrating the popularity of the Super One model [3] - The partnership with Golden Hills is expected to enhance revenue potential for both companies and improve sales conversion efficiency for the Super One in high-end vacation rental scenarios [4] Sales and Market Expansion - The deposit agreement with Golden Hills includes non-refundable deposits and non-binding pre-orders, with all deposits fully received [2] - This partnership represents a cross-industry expansion into high-end vacation rentals, following previous expansions into car rental, real estate brokerage, and peer-to-peer vehicle sharing [3] Product Development and Manufacturing - The first batch of pre-production vehicles for the FX Super One has started assembly at the FF aiFactory in Hanford, California, with a roll-off ceremony scheduled for December 21 [6][15] - The company is committed to accelerating production and has plans to preview its 2026 strategy during the ceremony [6] Financial and Strategic Initiatives - FF President Jerry Wang has received positive feedback from potential strategic investors in the Middle East, indicating increased interest in investment opportunities [7] - The company is actively engaging with U.S. government officials to advance its Global Automotive Bridge Strategy and discuss key topics such as local manufacturing and technological innovation [8][9] Future Plans - Faraday Future aims to explore more high-end consumer industries and innovative B2B2C models, which could serve as important user acquisition engines as the company scales [5]

Core Points - The Company announced the commencement of a subscription period for a Subsequent Offering of up to 22,222,222 new shares at a subscription price of NOK 0.90 per share [1] - The Board of Directors has decided to cancel the Subsequent Offering due to shares trading below the subscription price for a significant period, allowing shareholders to purchase shares at lower market prices [2] - Ensurge Micropower specializes in advanced microbattery technology for AI-enabled devices, focusing on thin-film batteries produced through high-precision roll-to-roll processes [3]

Core Insights - Kyverna Therapeutics, Inc. is set to host a live webcast and conference call on December 15, 2025, to discuss topline results from the Phase 2 KYSA-8 clinical trial for KYV-101 in stiff person syndrome [1][2] Company Overview - Kyverna Therapeutics is a clinical-stage biopharmaceutical company focused on developing cell therapies for autoimmune diseases, with its lead candidate KYV-101 advancing through late-stage clinical development [4] - KYV-101 is a fully human, autologous, CD19 CAR T-cell therapy designed for potency and tolerability, aiming for deep B-cell depletion and immune system reset [3][4] - The company is also conducting registrational trials for myasthenia gravis and has ongoing Phase 1/2 trials for lupus nephritis, with plans to explore additional indications such as multiple sclerosis and rheumatoid arthritis [4]

Core Insights - EVDANCE has released an expanded set of product recommendations and technical guidance for portable Level-1 and Level-2 EV chargers, addressing the growing need for safe and flexible home-charging solutions as electric vehicle ownership becomes more mainstream [1][15]. Product Recommendations - EVDANCE's updated recommendations aim to help EV owners select chargers that balance charging speed, safety, and convenience, suitable for various living situations including apartments and suburban homes [2]. - The recommended lineup includes three portable charging solutions: a 12A Level-1 unit, a 24A Level-2 dryer-outlet unit, and a 40A Level-2 smart charger, all available in Tesla-connector (NACS) and J1772 formats [4][19]. Charger Specifications - **12A Level-1 Charger**: Ideal for renters and users without 240V access, it operates at ~12A at 120V, suitable for overnight charging, and is ETL-listed with UL2594-aligned protections [5][6]. - **24A Level-2 Charger**: Designed for homeowners wanting a speed upgrade, it delivers up to 5.76 kW, providing approximately 20–25 miles of charge per hour, and connects to existing dryer outlets [7][8]. - **40A Level-2 Smart Charger**: Offers up to 9.6 kW for faster charging, features mobile app control for scheduling and monitoring, and is suitable for heavy daily mileage [9][10]. Safety and Certification - EVDANCE emphasizes the importance of device certification, specifically UL2594 and ETL testing, to ensure safety and performance for EV supply equipment in North America [3]. - Each charger includes built-in protections such as overcurrent and overvoltage protections, thermal management, and ground-fault detection, ensuring safe operation under various conditions [14][17][18]. Practical Use Cases - The 12A Level-1 model is recommended for renters and low-mileage drivers, while the 24A Level-2 units are suitable for multi-home owners and apartments with dryer outlets [11]. - The 40A smart charger is ideal for frequent long-distance drivers, and all portable chargers can serve as reliable backups during travel [12]. Interoperability - EVDANCE offers both NACS and J1772 connector versions across its product lineup, making the chargers compatible with various EV manufacturers and future-proof for mixed-fleet households [19]. Company Overview - EVDANCE is dedicated to creating safe, portable, and high-performance EV charging solutions, focusing on reliability and rigorous safety validation to meet the needs of diverse users [20].

Update on the Flamanville EPR: the reactor has reached 100% of nuclear thermal power 14 December 2025 marks a major milestone : the Flamanville 3 reactor reached 100% nuclear thermal power at 11:37am and generated 1,669MW of gross electrical power*. The ramp-up to 100% nuclear thermal power follows the approval by the French nuclear safety and radiation protection authority (ASNR) on 12 December 2025, to go beyond the 80% threshold. Reaching the 100% mark for the first time enables testing of equipment a ...

Core Viewpoint - InnoCare Pharma announced that the phase IIb clinical study of its BTK inhibitor orelabrutinib has successfully met its primary endpoint in treating systemic lupus erythematosus (SLE) and has received approval for a phase III trial [1][8]. Clinical Study Results - Orelabrutinib showed significant efficacy and a well-tolerated safety profile in SLE patients after 48 weeks of treatment, with 187 patients enrolled in the study [2][6]. - The primary endpoint, SLE Response Index-4 (SRI-4) response rate at week 48, was achieved with the 75 mg QD group showing a response rate of 57.1% compared to 34.4% in the placebo group (p < 0.05) [3]. - The 75 mg QD group also demonstrated better efficacy than the 50 mg QD group, indicating a dose-dependent improvement [3]. Secondary Endpoint and Subgroup Analysis - At week 48, the 75 mg QD group met secondary endpoints with significantly higher SRI-6 and BICLA response rates compared to placebo (p < 0.05) [4]. - In patients with baseline BILAG ≥1A or ≥2B, the placebo-adjusted difference in SRI-4 response rate for the 75 mg QD group was 35%, and for those with a clinical SLEDAI-2K score ≥4, it was 43% [5]. Safety Profile - Orelabrutinib was well tolerated among SLE patients, with a safety profile consistent with BTK inhibition and the disease's biology [6]. Market Potential and Company Overview - Orelabrutinib is the first BTK inhibitor to show significant efficacy in a phase II clinical trial for SLE, with expectations to become a first-in-class oral treatment [7]. - SLE affects approximately 8 million people globally, with around 1 million patients in China, highlighting a significant unmet medical need [8]. - InnoCare is focused on developing first-in-class and best-in-class drugs for cancer and autoimmune diseases, with operations in multiple locations including China and the United States [9].

Core Points - Rocket Lab Corporation successfully launched its first dedicated mission for the Japan Aerospace Exploration Agency (JAXA), marking a significant milestone for the Electron rocket in providing reliable access to space [1][2] - The "RAISE And Shine" mission deployed the RApid Innovative payload demonstration SatellitE-4 (RAISE-4), showcasing eight technologies developed by various Japanese entities [2] - This launch reflects the increasing collaboration between commercial companies and national space programs, with Rocket Lab being a leader in small launch services [3] Company Highlights - Rocket Lab's founder and CEO, Sir Peter Beck, emphasized the precision and reliability of the mission, supporting the growth of Japan's aerospace economy [4] - The "RAISE And Shine" mission was Rocket Lab's 19th launch of the year, contributing to a new annual launch record established just a month prior [4] - Upcoming launches include a second mission for JAXA scheduled for Q1 2026 and a dedicated launch for the European Space Agency (ESA) [3][4] Industry Context - The successful launch for JAXA illustrates the growing integration of commercial entities into national space initiatives, enhancing the global demand for Rocket Lab's Electron rocket [3] - Rocket Lab's Electron rocket is recognized as the world's most frequently launched orbital small rocket, indicating its strong position in the market [5]

Core Viewpoint - Exor's Board of Directors has unanimously rejected Tether's unsolicited proposal to acquire its controlling stake in Juventus Football Club, reaffirming its commitment to the club and its management strategy [1][2]. Group 1: Exor's Position on Juventus - Exor has consistently stated that it has no intention of selling any shares in Juventus to any third party, including Tether [2]. - The Agnelli family, as stable shareholders for over a century, remains fully committed to Juventus and supports its new management team [2]. Group 2: About Exor - Exor N.V. has been making successful investments worldwide for over a century, driven by a culture that combines entrepreneurial spirit and financial discipline [3]. - The company's portfolio includes major holdings in companies such as Ferrari, CNH, Stellantis, and Philips, where Exor is the largest shareholder [3].